Table 2.
Comparison of measurable outcomes in ICU patients in dedicated pharmacist group versus control group
| Outcomes | Dedicated pharmacist group (n = 55) | Control group (n = 71) | P |
| Mean (SD) drug charges, $ | 3,362 (5,770) | 3,225 (4,827) | .88a |
| Mean (SD) ICU LOS, days | 5.25 (5.50) | 6.60 (10.10) | .34a |
| Total LOS per group, days | 307 | 475 | |
| Preventable ADE incidents, n | |||
| All | 7 | 14 | .40b |
| Excluding weekend/holiday | 3 | 13 | .03 |
| ADEs per 1,000 patient days | |||
| All | 23 | 31 | |
| Excluding weekend/holiday | 10 | 28 | |
Note: ADE = adverse drug event; ICU = intensive care unit; LOS = length of stay.
a
Significance level (P value) for analysis of variance statistical analysis.
b
Significance level (P value) for chi-square statistical analysis.